Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardiovascular Catch-Up: Philips New AI Finds AF Needle In ECG Haystack; LimFlow Moves Closer To US Approval

Executive Summary

Medtech Insight’s Cardiovascular Catch-Up highlights recent news and insights from cardiovascular device companies – big and small. Part two of this month's installment includes updates from lesser-known companies that you might have missed, including Cardiologs, Rhythm Management, LimFlow and ShockWave.

You may also be interested in...



Minute Insight: Biotronik Launches Remote Monitor That Can Prevent Heart Failure Hospitalizations

The HeartInsight algorithm combines heart failure parameters into a predictive score and alerts physicians if a patient with an implanted ICD or CRT-D is at higher risk of hospitalization. Biotronik will roll out HeartInsight in Europe in April.

Remote Monitoring A Potential Strategy To Recruit Older Adults Into Oncology Trials

Final FDA guidance also suggests sponsors recruit representative populations and limit exclusions.

Cardiologs’ AI Trial Demonstrates Effectiveness Of Remote ECG Monitoring

Cardiologs has completed a clinical trial ECG analysis platform with implantable loop recorders. It can remotely identify features that have previously been a burden to physicians.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145282

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel